ARTICLE | Clinical News
Exocell regulatory update
June 17, 1996 7:00 AM UTC
Exocell received U.S. Patent No. 5,518,720 covering treatment with its A717 monoclonal antibody for kidney disease and other complications of diabetes. The MAb binds to and neutralizes glycated album...